DBVT DBV TECHNOLOGIES SA US FDA Inspections 8-K Filing 2024 - FDA Approval Pathway DBV Technologies announced alignment with the U.S. FDA on an accelerated approval pathway for the Viaskin Peanut Patch aimed at toddlers aged 1 to 3 years.Get access to all SEC 8-K filings of the DBV TECHNOLOGIES SA